Yao Shengpeng, Zhang Hong
Department of Thyroid Surgery, The Second Hospital of Jilin University, Changchun, China.
Front Endocrinol (Lausanne). 2025 Apr 11;16:1512417. doi: 10.3389/fendo.2025.1512417. eCollection 2025.
Thyroid cancer is a malignant tumor of the endocrine system. Papillary thyroid carcinoma (PTC) is the most common form of thyroid cancer and has a comparatively better prognosis. An autoimmune disease called Hashimoto's thyroiditis (HT) affects the thyroid and can cause lymphocyte infiltration in the thyroid tissue as well as hypothyroidism, which is characterized by increased levels of a certain antibody. It is currently assumed that there is a connection between PTC and HT. HT may increase the incidence of PTC and improve its prognosis by regulating gene expression, participating in common signaling pathways, and creating a specific immune microenvironment. In this review, we summarized the relationship between HT and PTC as well as the effects of coexisting HT on PTC and the possible mechanisms, thereby providing new perspectives for future research.
甲状腺癌是一种内分泌系统的恶性肿瘤。甲状腺乳头状癌(PTC)是甲状腺癌最常见的形式,预后相对较好。一种名为桥本甲状腺炎(HT)的自身免疫性疾病会影响甲状腺,可导致甲状腺组织淋巴细胞浸润以及甲状腺功能减退,其特征是某种抗体水平升高。目前认为PTC与HT之间存在联系。HT可能通过调节基因表达、参与共同信号通路以及创建特定免疫微环境来增加PTC的发病率并改善其预后。在本综述中,我们总结了HT与PTC之间的关系以及共存的HT对PTC的影响和可能的机制,从而为未来研究提供新的视角。